Evolution of Poly(ADP-ribose) Polymerase-1 (PARP-1) Inhibitors. From Concept to Clinic

被引：303
作者：
Ferraris, Dana V. [1 ]
机构：
[1] Johns Hopkins Univ, Brain Sci Inst, Baltimore, MD 21205 USA
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2010年 / 53卷 / 12期
关键词：
RESISTANCE-MODIFYING AGENTS; DNA-DAMAGE RESPONSE; POTENT INHIBITORS; IN-VITRO; QUINAZOLINONE INHIBITORS; BENZIMIDAZOLE INHIBITORS; MYOCARDIAL PROTECTION; BIOLOGICAL EVALUATION; ISCHEMIC INJURIES; ADP-RIBOSYLATION;
D O I：
10.1021/jm100012m
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
[No abstract available]
引用
收藏
页码：4561 / 4584
页数：24
相关论文
共 154 条
[1]  
Abdelkarim GE, 2001, INT J MOL MED, V7, P255
[2]   Poly(ADP-ribose) turnover in quail myoblast cells: Relation between the polymer level and its catabolism by glycohydrolase [J].
Affar, EB ;
Shah, RG ;
Poirier, GG .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1999, 193 (1-2) :127-135
[3]  
ANRAKU T, 2005, STROKE, V36, P393
[4]   Involvement of poly(ADP-ribose) polymerase-1 and XRCC1/DNA ligase III in an alternative route for DNA double-strand breaks rejoining [J].
Audebert, M ;
Salles, B ;
Calsou, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (53) :55117-55126
[5]  
AUDEH MW, 2009, ASCO M 2009 ASCO ANN, V27, P5500
[6]  
BANASIK M, 1992, J BIOL CHEM, V267, P1569
[7]   INHIBITORS AND ACTIVATORS OF ADP-RIBOSYLATION REACTIONS [J].
BANASIK, M ;
UEDA, K .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1994, 138 (1-2) :185-197
[8]  
BARTH F, 2004, Patent No. 6794382
[9]   A Phase IB Trial of Intravenous INO-1001 Plus Oral Temozolomide in Subjects with Unresectable Stage-III or IV Melanoma [J].
Bedikian, Agop Y. ;
Papadopoulos, Nicholas E. ;
Kim, Kevin B. ;
Hwu, Wen-Jen ;
Homsi, Jade ;
Glass, Michelle R. ;
Cain, Suzanne ;
Rudewicz, Patrick ;
Vernillet, Laurent ;
Hwu, Patrick .
CANCER INVESTIGATION, 2009, 27 (07) :756-763
[10]   Myocardial protection at a crossroads - The need for translation into clinical therapy [J].
Bolli, R ;
Becker, L ;
Gross, G ;
Mentzer, R ;
Balshaw, D ;
Lathrop, DA .
CIRCULATION RESEARCH, 2004, 95 (02) :125-134
12345678910